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The aim of this study is to assess the potential effectiveness, acceptability and feasibility of a brief smoking cessation intervention
delivered as part of cervical screening. A cluster randomised controlled trial was conducted with clinic week as the unit of
randomisation, comparing a group (n¼121) receiving brief smoking cessation advice supplemented with written information given by
practice nurses during cervical smear test appointments, with a group (n¼121) not receiving this advice. Outcomes were intention
to stop smoking (potential effectiveness); intention to attend for future cervical screening (acceptability); duration of intervention
(feasibility). 172/242 (71%) and 153/242 (63%) participants completed 2-week and 10-week follow-ups, respectively. Compared to
women in the control group, those in the intervention group had higher intentions to stop smoking at 2-weeks (adjusted mean
difference 0.51, 95% CI:  0.02 to 1.03, P¼0.06) and 10-weeks (adjusted mean difference 0.80, 95% CI 0.10 to 1.50, P¼0.03). The
two groups had similarly high intentions to attend for future screening. Consultations in the intervention arm took a mean of 4.98min
(95% CI: 3.69 to 6.27; Po0.001) longer than the control arm. In conclusion, brief smoking cessation advice given by practice nurses as
part of cervical screening seems acceptable, feasible and potentially effective. Evidence is lacking on the effectiveness and cost
effectiveness of this intervention in achieving biochemically validated smoking cessation.
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A report from the International Agency for Research on Cancer
from an Expert Group highlights the need for systematic study
of the feasibility of combining routine screening with health
education and its consequences as part of their proposed strategy
for the development of research in the behavioural, social and
related sciences relevant to cancer (IARC, 2004). Smoking is a risk
factor for many diseases including some in which screening is
available. These include cervical cancer, colorectal cancer, heart
disease and abdominal aortic aneurysms. Screening provides an
opportunity to inform smokers of the health risks of smoking and
to motivate smoking cessation. However, evidence is needed to
show that such interventions are effective and that they do no
harm, such as deterring people from re-attending for screening.
The aim of the current study is to generate preliminary evidence
regarding the impact of providing brief smoking cessation advice
as part of screening for cervical cancer.
Smoking doubles the chance of developing cervical cancer
(Szarewski and Cuzick, 1998) and is an independent predictor of
treatment failure in women with cervical intraepithelial neoplasia
(Acladious et al, 2002). Stopping smoking can result in low-grade
lesions remitting within 6 months (Szarewski et al, 1996); many
women are unaware of this (Marteau et al, 2002). Written
information about the link between smoking and cervical cancer
increases motivation to stop smoking (Hall et al, 2003, 2004; Bishop
et al, 2005). The effectiveness of this information could be increased
if combined with verbal smoking cessation advice (Lancaster and
Stead, 2005). Although it has been suggested that smokers are less
likely than non-smokers to attend for cervical screening (Orbell et al,
1995), evidence concerning this association is equivocal with other
studies finding no association (Clark et al, 2000). Since 81% of
women aged between 25 and 64 in England participate in the cervical
screening programme (Patnick, 2003), this time provides an ideal
opportunity to deliver effective smoking cessation interventions to
reduce the high rates of smoking in women, reducing risks of
cervical cancer as well as other smoking-related diseases.
Brief smoking cessation advice from physicians is effective
(Lancaster and Stead, 2004). A Cochrane review of nurses’ smoking
cessation interventions shows that nurses are effective in motivat-
ing smokers to quit. These interventions, however, were generally
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smore intensive than those given by physicians and the evidence
is not strong for an effect when it is provided as part of a health
check in general practice (Rice and Stead, 2004). We are unaware
of any suitably powered studies in primary care evaluating the
impact of brief, opportunistic smoking cessation advice delivered
by nurses. It is also important to ensure that giving unsolicited
smoking cessation advice does not annoy women (Butler et al,
1998) or deter them from attending for future cervical screening.
Such direct evidence is needed to inform the recent policy in the
UK which states that nurses in primary care should deliver brief
smoking cessation advice to everyone who smokes (National
Institute for Clinical Excellence, 2006). The current pilot study
assesses the potential effectiveness, acceptability and feasibility of
a brief smoking cessation intervention delivered by nurses in the
context of a cervical screening consultation, to inform the decision
about the need for a clinical trial.
MATERIALS AND METHODS
Participants
The study population consisted of smokers attending for cervical
screening between January and December 2004. Women were
invited for screening as part of the national cervical cancer
screening programme. One practice nurse, currently conducting
cervical smear tests from each of eight general practices located in
the south east of England that are part of the Medical Research
Council General Practice Research Framework, participated in the
study. Women were eligible to participate if they smoked at least
one cigarette a day and understood spoken English. We excluded
women from the study if they were participating in any other
intervention study (see Figure 1). In addition, GPs checked weekly
lists of eligible women and excluded those whom they judged
should not be approached.
Ethical approval
The Metropolitan Multi-Centre Research Ethics Committee (03/11/
067) and all relevant local research ethics committees approved the
study.
Randomisation
Clinic weeks (clusters) were the units of randomisation, with all
women attending for a smear test at the study practices in a given
week allocated to the same trial arm (Donner and Klar, 2000). We
considered two other units of randomisation for this study: (a)
cluster randomisation with GP practices as the unit of randomisa-
tion and (b) randomisation by patient. With a larger study (20 or
more practices), cluster randomisation by GP practice would have
been preferred. However, with just eight practices, it would not
have been possible either to estimate precisely the intra-cluster
(intra-practice) correlation coefficient at analysis or to use
adjusted individual-level methods (Ukoumunne et al, 1999).
Randomisation by patient would have avoided this issue, but,
because nurses would have frequently had to switch from
intervention to control procedures, this would have had the
highest likelihood of contamination between the trial arms. We
therefore chose randomisation by clinic week because, with
relatively few women attending each week, the variance inflation
factor (Ukoumunne et al, 1999) was likely to be small and the
likelihood of contamination was at least reduced, since nurses were
instructed at the end of the preceding week to take only the study
packs for either the intervention or the control arms for the
following week. Clinic weeks were randomly allocated by the study
statistician (OU) to the trial arms using computer-generated
random numbers. Block randomisation (Roberts and Torgerson,
1998) was used with three different random block sizes of two, four
and six to prevent long sequences of clinic weeks being
randomised to the same trial arm. At the end of each week during
the recruitment period, the study coordinator (SH) informed
nurses whether the following week would be an intervention or a
control week. As a consequence of these arrangements, there was
no allocation concealment.
Procedure
The receptionist gave all women attending for routine cervical
smear tests information to read about the study while they were
waiting to see the nurse. This clearly stated that the information
was only relevant to smokers. Before conducting the smear test,
nurses asked women if they smoked. If women reported that they
Assessed for eligibility (n=1264) 
Randomised (n=242)  Excluded (n=1022)
Non-smoker=905 
Excluded by GP=8 
Involved in other research=4 
Declined participation=50 
Other=55 
Allocated to Intervention group (n=121) 
all received the intervention 
Allocated to Control group (n=121) 
Total analysed at 2-week 
follow-up (n=172/242) 
Total lost to follow up 
(n=70/242) 
2-week follow-up completed 
Control group (n=82/121)
2-week follow-up completed
Intervention group (n=90/121) 
Total analysed at 10-week 
follow-up (n=153/242) 
Total lost to follow up 
(n=89/242)
10-week follow-up completed 
Control group (n=74/121)
   10-week follow-up completed 
Intervention group (n=79/121) 
Figure 1 Movement of women through the study.
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ssmoked, nurses checked their understanding of the information
sheet, provided clarifications where necessary and then invited
them into the study.
During intervention weeks, nurses delivered brief smoking
cessation advice as part of the smear test visit to all smokers who
consented to take part in the study. In control weeks they did not
give smoking cessation advice.
The intervention
Nurses delivered the intervention to each participant just once.
The intervention was designed to take about 3min to deliver. We
based the advice on the ‘5 As’ designed for health professionals
assisting patients in stopping smoking (Ask, Advise, Assess, Assist
and Arrange) for which there is evidence of effectiveness (West,
McNeill and Raw, 2000). As recommended in The Expert Patient
Programme (Department of Health, 2001), we trained nurses to
give advice in a way that builds rapport and is patient-centred.
In addition, nurses gave all women in the intervention group an
information pack containing: (a) the leaflet we developed for the
study: Smoking and Women’s Health; (b) the self-help booklet
produced by the Department of Health: Giving up for life; (c) the
booklet produced by QUIT: Quit smoking without putting on
weight; and (d) a card listing local and national smoking cessation
services.
All nurses received one and a half days of training in giving
smoking cessation advice. Medical Research Council General
Practice Research Framework regional training nurses visited each
nurse to undertake a structured quality control assessment to
ensure nurse compliance with the protocol.
Measures
We assessed outcomes by postal questionnaire 2 weeks and
approximately 10 weeks after the consultation. We sent most
women questionnaires 10 weeks after recruitment. However, if test
results had not been sent by 10 weeks, we delayed sending the
second questionnaire until a week had passed since test results
had been sent. Nine women chose to complete these measures by
telephone. We sent one reminder to those who had not responded
within 2 weeks.
Since this study is aimed at providing a ‘proof of principle’, our
main outcome is intention to stop smoking in the next month
(potential effectiveness). We used two, seven-point scales at the
2- and 10-week follow-ups. As these produced a reliable measure
(Cronbach’s a¼0.81 at 2 weeks and 0.91 at 10 weeks), we used the
mean of the two items in the analyses. We also collected self-
reported smoking status. We assessed the feasibility of the
intervention by estimating the time taken for the intervention.
We assessed the acceptability of the intervention to women by
measuring intention to return for next cervical smear test
appointment using a single, seven-point scale. As this measure
was highly skewed we dichotomised it (definitely intending: score
7, vs other: scores 1–6). Baseline readiness to stop smoking
(contemplators: planning to stop within the next 6 months; pre-
contemplators: not planning to do so) and demographic measures
was collected by nurses before the intervention. Results of current
smear tests were obtained from practice nurses.
Sample size
We planned to detect an effect size of 0.42 standard deviation units
in mean intention to stop smoking in the next month between the
intervention and control groups, with 80% power at the (two-
tailed) 5% level of significance. This is the effect size found in our
leaflet evaluation (Hall et al, 2004), and corresponds to a medium
effect (Cohen, 1988). In a trial randomising individuals, 89
participants would be required in each trial group. After inflating
this sample size by 10% to allow for a possible variance inflation
factor resulting from the randomisation by clinic weeks rather
than individual participants (Ukoumunne et al, 1999), and a
further 30% to allow for loss to follow-up, a total of 288
participants are required. We planned to recruit 36 smokers from
each of the eight participating general practices.
Statistical analysis
Analyses were conducted using the intention to treat principle as
far as possible, given missing data. Analyses of drop-out status
were implemented. Intention to stop smoking and length of smear
test consultation were compared between trial arms using random
effects linear regression models (Goldstein, 1995) fitted using
restricted maximum likelihood estimation to allow for clustering
of participant responses within randomised weeks. As these
measures were skewed, the non-parametric bootstrap (Davison
and Hinkley, 1997) was used to validate the confidence intervals,
resampling weeks (clusters) rather than individuals. As the
bootstrap confidence intervals were similar to the model-based
intervals, we report the latter. Comparison of the 2- and 10-week
outcomes were adjusted for age, ethnic group, education level,
baseline motivation to stop smoking and whether the participant
had previously had an abnormal cervical smear test result.
Comparison of the 10-week outcome was additionally adjusted
for whether the index smear result was normal. As few women
reported stopping smoking, and most reported definitely intend-
ing to return for future smear tests, it was not possible to adjust
these analyses for confounders or clustering. We conducted
Fisher’s exact tests for these dichotomous outcomes. All analyses
were carried out using Stata 9.2 (StataCorp, 2005).
RESULTS
The final sample comprised 121 women in each trial arm (Figure 1).
The GPs excluded eight women. The proportion of women who
declined to participate did not differ between the intervention (31
out of 152, 20%) and control weeks (19 out of 140, 14%) (w
2¼2.39,
d.f.¼1, P¼0.12). Baseline and demographic characteristics of
the intervention and control groups are shown in Table 1. About
26 (31 out of 121) and 32% (39 out of 121) participants in the
intervention and control arms, respectively, were lost to follow-up
at 2 weeks. About 35 (42 out of 121) and 39% (47 out of 121)
participants in the intervention and control arms, respectively,
were lost to follow-up at 10 weeks. Non-responders at the 2- and
10-week follow-ups were younger, and non-responders at the 10-
week follow-up were more likely to have received a normal result
on their current smear test. Smokers educated to GCSE ‘O’ level
standard or less were more likely to be lost to follow-up if they
were randomised to the control group than their counterparts in
the intervention group. None of these variables, however, was
associated with intention to stop smoking.
Outcomes
The outcomes are summarised in Table 2. Compared to women in
the control group, those in the intervention group had higher
intentions to stop smoking, both at the 2- (P¼0.06) and 10-week
(P¼0.03) follow-ups. More women in the intervention arm than
the control arm reported smoking cessation at 10 weeks (12 vs 5,
P¼0.13), but the difference was not significant at the 5% level.
Intentions to attend for next cervical smear test were high at 2
weeks and 10 weeks in both trial arms. The mean time taken to
complete the smear test consultation was longer in the intervention
arm than in the control arm (mean difference 4.98min; 95% CI:
3.69–6.27; Po0.001).
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This study suggests that a brief smoking cessation intervention
given by trained practice nurses as part of routine cervical
screening is acceptable, feasible and has the potential to motivate
women to stop smoking without deterring them from attending for
future cervical screening.
A priority in developing this intervention was to ensure that it
was feasible to incorporate it into routine cervical screening
appointments, and that it did not have the unintended effect of
deterring women from attending for future cervical screening. The
intervention took longer to deliver than the planned 3min. This
may reflect women’s interest in the link between smoking and
cervical cancer and their willingness to discuss their smoking with
these nurses trained to give advice in a patient-centred manner.
Although it has been suggested that unsolicited smoking cessation
advice can annoy patients (Butler et al, 1998), a qualitative study of
16 women in the intervention group of the current study found
that they raised no objections to being giving smoking cessation
advice from the trained nurses. The results of the current study
also show that providing such advice does not diminish intentions
to return for future cervical smear tests.
In addition to doing no harm, the intervention increased
women’s intentions to stop smoking in the next month evident
both at 2- and 10-week follow-ups. This raises two questions: (i)
how effective is the intervention likely to be in achieving actual
quitting, and (ii) is there sufficient uncertainty in this answer to
justify an RCT? Objectively measured behaviour, in this case,
biochemically validated smoking cessation, is a harder outcome
than intentions to stop smoking in the next month and, where
appropriate (e.g. in the conduct of a clinical trial), they are the end
point of choice. The current study did not use behaviour as the end
point as it was designed to assess the acceptability, feasibility and
potential effectiveness of the intervention before a clinical trial.
Nonetheless, intentions are a reliable predictor of health-related
behaviour, including smoking (Armitage and Connor, 2001).
Intentions not to engage in a behaviour are highly predictive of
not doing so, whereas intentions to engage in a behaviour are less
reliable (Sheeran and Orbell, 1998). Thus, if a smoking cessation
intervention has no impact on intentions to stop smoking, it is
highly unlikely that such an intervention will achieve smoking
cessation. If, however, an intervention does increase intentions to
stop smoking, then it is possible that it could result in smoking
cessation. It is therefore informative to use intentions to stop
smoking as an end point for a study designed to assess the
potential effectiveness of an intervention. Failure to find an impact
upon intentions would avoid the costs of conducting a trial
powered on smoking cessation as the end point. In keeping with
the MRC framework for evaluating complex interventions, the
current study can be seen as collecting theoretical and empirical
evidence for the likely effectiveness of the intervention (Medical
Research Council, 2000).
We cannot judge with much confidence the size of effect the
current intervention is likely to have in achieving smoking
cessation. We believe that the results of this pilot study warrant
a randomised controlled trial to evaluate the intervention for its
effectiveness and cost-effectiveness at achieving biochemically
validated smoking cessation (estimated to involve 7200 smokers),
given the importance of developing cost-effective smoking
cessation interventions (World Health Organization, 2003), the
uncertainty attached to using intention as a proxy for actual
behaviour change, and the opportunity cost of delivering an
ineffective intervention.
The main strength of this study is that, to the best of our
knowledge, it is the first study in UK primary care to determine
the impact of opportunistic brief smoking cessation advice from
nurses when effective smoking cessation services are readily
available. It is also the first to consider the possible harms of
delivering such interventions as part of routine screening.







Age Mean (s.d.) 38.7 (11.8) 39.3 (12.1)
Baseline stage of change
Pre-contemplation n (%) 53 (44) 61 (50)
Contemplation n (%) 67 (55) 60 (50)
Missing n (%) 1 (1) 0 (0)
Ethnic group
White n (%) 113 (93) 111 (92)
Other n (%) 8 (7) 10 (8)
Education
GCSE ‘O’ level or less n (%) 68 (56) 64 (53)
‘A’ level or higher n (%) 53 (44) 57 (47)
Previous cervical abnormality
Yes n (%) 52 (43) 39 (32)
No n (%) 66 (55) 82 (68)
Missing n (%) 3 (2) 0 (0)
Current smear test result
Normal n (%) 97 (80) 96 (79)
Abnormal/borderline n (%) 24 (20) 23 (19)
Inadequate/unclear n (%) 0 (0) 2 (2)
Table 2 2- and 10-week outcomes by randomisation group
Outcome Intervention Control Difference
Adjusted mean
difference 95% CI P-value
2-week follow-up n¼90 n¼82
Stopped smoking, n (%) 3 (3) 2 (2) 1.00
Intention to stop smoking in the next month, mean (s.d.) 2.86 (1.80) 2.29 (1.71) 0.51  0.02 to 1.03 0.06
Definitely intend to go for next cervical smear test, n (%) 86 (97) 74 (90) 0.12
10-week follow-up n¼79 n¼74
Stopped smoking, n (%) 12 (15) 5 (7) 0.13
Intention to stop smoking in the next month, mean (s.d.) 3.13 (2.04) 2.24 (1.58) 0.80 0.10–1.50 0.03
Definitely intend to go for next cervical smear test, n (%) 74 (94) 70 (95) 1.00
Sample size for adjusted analysis of intention to stop smoking was 83 in the intervention arm and 77 in the control arm at 2 weeks, and 65 in the intervention arm and 67 in the
control arm at 10 weeks.
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sThe main weaknesses concern: the main outcome measure, the
response rates to the questionnaires and nurses not being blinded
to group allocation. As described above, intentions to stop
smoking are a proxy measure of smoking cessation. However,
the aim of the study was not to detect a change in behaviour but
rather to demonstrate the feasibility of a clinical trial as well as
provide ‘proof of principle’ (Medical Research Council, 2000) of an
innovative smoking cessation intervention. We are now arguing
that the results of this pilot study support the case for a trial. The
proportion of participants lost to 10-week follow-up was greater
than expected. This introduces potential bias, the nature and scale
of which is unknown. It underscores the need for future studies in
this area to assess outcome measures using methods with higher
response rates. These include participant payment and telephone
administered questionnaires (McColl et al, 2001). Another
weakness and potential source of bias in the current study is the
lack of allocation concealment, that is the nurses knew at the time
of recruitment the treatment arm to which women were to be
randomised. This could have led to selection bias with different
numbers of women with different characteristics being recruited
during the intervention compared with the control weeks (Medical
Research Council, 2002, pp 4–5). The fact that equal numbers of
women were recruited to each arm suggests that this may not have
been a serious problem in this trial. Women in the intervention
arm were more likely to have had a previous abnormal cervical
smear test result than those in the control arm (43 vs 32%), but
otherwise there were no marked differences in demographic or
baseline characteristics between the women in the two trial arms.
In conclusion, the results of this study suggest that brief
smoking cessation advice given by practice nurses during routine
cervical smear test appointments is acceptable, feasible and
potentially effective. Evidence is lacking on the effectiveness and
cost-effectiveness of this intervention in achieving biochemically
validated smoking cessation. Such evidence is needed to inform
current practice and health policies in the UK and elsewhere aimed
at reducing deaths from smoking.
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